Cervical abscess in an immunocompetent patient with Mycobacterium malmoense pulmonary disease

被引：2

作者：

Duarte J.N. ^{[1
]}

Marques N. ^{[2
]}

Barroso L. ^{[1
]}

Ramos I. ^{[2
]}

Sá R. ^{[2
]}

Sanz D. ^{[1
]}

Ferreira A. ^{[1
]}

da Cunha S. ^{[2
]}

机构：

[1] Maxillofacial Surgery Department, University Hospitals of Coimbra, 3000-076 Coimbra, Avenida Bissaya Barreto

[2] Infectious Diseases Department, University Hospitals of Coimbra, 3000-076 Coimbra, Avenida Bissaya Barreto

来源：

Oral and Maxillofacial Surgery | 2012年 / 16卷 / 3期

关键词：

Abscess; Disseminated atypical mycobacterial infection; Mycobacterial cervical lymphadenitis; Mycobacterium;

D O I：

10.1007/s10006-011-0306-5

中图分类号：

学科分类号：

摘要：

Background: Mycobacterium malmoense is a nontuberculous mycobacteria seen mainly in two age groups and with different clinical presentations. Most patients are male adults presenting clinical symptoms and signs similar to those of pulmonary tuberculosis. The second group is formed by immunocompetent children with localized cervical lymphadenitis. Although cervical adenitis is the main extrapulmonary manifestation of M. malmoense, virtually all cases of cervical disease were documented in children. Disseminated disease is rare and has been reported in patients with severely impaired immunity. Case report: We report a case of a 47-year-old immunocompetent man with a cervical abscess, in whom we identified a M. malmoense pulmonary disease with multiple cervical, thoracic and abdominal adenopathies. Conclusion: Extrapulmonary infection due to M. Malmoense needs to be considered on the differential diagnosis of cervical masses and adenopathies, not only in pediatric patients but also in adults with no impaired immunity. A high index of suspicion for nontuberculous mycobacteria is essential for the diagnosis and prognosis. © 2011 Springer-Verlag.

引用

页码：321 / 325

页数：4

共 25 条

[1] Hoefsloot W., Boeree M.J., van Ingen J., Bendien S., Magis C., de Lange W., Et al., The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature, Int J Tuberc Lung Dis, 12, pp. 987-993, (2008)
[2] Schroder K.H., Juhlin I., Mycobacterium malmoense sp. nov, Int J Syst Bacteriol, 27, pp. 241-246, (1997)
[3] Martin-Casabona N., Bahrmand A.R., Bennedsen J., Thomsen V.O., Curcio M., Fauville-Dufaux M., Et al., Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey, Int J Tuberc Lung Dis, 8, pp. 1186-1193, (2004)
[4] Jenkins P.A., Mycobacterium malmoense, Tubercle, 66, pp. 193-195, (1985)
[5] McGrath E.E., Anderson P.B., Increased prevalence of non-tuberculous mycobacteria infection, Lancet, 370, (2007)
[6] Lamden K., Watson J.M., Knerer G., Ryan M.J., Jenkins P.A., Opportunist mycobacteria in England and Wales: 1982 to 1994, Commun Dis Rep CDR Rev, 6, (1996)
[7] Zaugg M., Salfinger M., Opravil M., Luthy R., Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review, Clin Infect Dis, 16, pp. 540-549, (1993)
[8] Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment, Eur Respir J, 21, pp. 478-482, (2003)
[9] Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., Et al., An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med, 175, pp. 367-416, (2007)
[10] Buchholz U.T., McNeil M.M., Keyes L.E., Good R.C., Mycobacterium malmoense infections in the United States, January 1993 through June 1995, Clin Infect Dis, 27, pp. 551-558, (1998)

← 1 2 3 →